BVNKF
Price
$36.30
Change
-$0.81 (-2.18%)
Updated
Jul 25 closing price
Capitalization
2.86B
IMRN
Price
$1.72
Change
-$0.02 (-1.15%)
Updated
Jul 25 closing price
Capitalization
11.8M
33 days until earnings call
Interact to see
Advertisement

BVNKF vs IMRN

Header iconBVNKF vs IMRN Comparison
Open Charts BVNKF vs IMRNBanner chart's image
Bavarian Nordic A/S
Price$36.30
Change-$0.81 (-2.18%)
Volume$208
Capitalization2.86B
Immuron
Price$1.72
Change-$0.02 (-1.15%)
Volume$73.68K
Capitalization11.8M
BVNKF vs IMRN Comparison Chart in %
Loading...
BVNKF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BVNKF vs. IMRN commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVNKF is a Hold and IMRN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (BVNKF: $36.30 vs. IMRN: $1.72)
Brand notoriety: BVNKF and IMRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BVNKF: 32% vs. IMRN: 23%
Market capitalization -- BVNKF: $2.86B vs. IMRN: $11.8M
BVNKF [@Biotechnology] is valued at $2.86B. IMRN’s [@Biotechnology] market capitalization is $11.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVNKF’s FA Score shows that 0 FA rating(s) are green whileIMRN’s FA Score has 1 green FA rating(s).

  • BVNKF’s FA Score: 0 green, 5 red.
  • IMRN’s FA Score: 1 green, 4 red.
According to our system of comparison, BVNKF is a better buy in the long-term than IMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BVNKF’s TA Score shows that 6 TA indicator(s) are bullish while IMRN’s TA Score has 3 bullish TA indicator(s).

  • BVNKF’s TA Score: 6 bullish, 3 bearish.
  • IMRN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BVNKF is a better buy in the short-term than IMRN.

Price Growth

BVNKF (@Biotechnology) experienced а +35.12% price change this week, while IMRN (@Biotechnology) price change was +0.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

IMRN is expected to report earnings on Aug 29, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BVNKF($2.86B) has a higher market cap than IMRN($11.8M). BVNKF YTD gains are higher at: 37.970 vs. IMRN (1.176). BVNKF has higher annual earnings (EBITDA): 2.01B vs. IMRN (-7.35M). BVNKF has more cash in the bank: 1.24B vs. IMRN (7.74M). BVNKF has higher revenues than IMRN: BVNKF (6.23B) vs IMRN (6.54M).
BVNKFIMRNBVNKF / IMRN
Capitalization2.86B11.8M24,237%
EBITDA2.01B-7.35M-27,393%
Gain YTD37.9701.1763,227%
P/E Ratio13.70N/A-
Revenue6.23B6.54M95,246%
Total Cash1.24B7.74M15,977%
Total Debt117MN/A-
FUNDAMENTALS RATINGS
BVNKF vs IMRN: Fundamental Ratings
BVNKF
IMRN
OUTLOOK RATING
1..100
2648
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
22
Undervalued
PROFIT vs RISK RATING
1..100
81100
SMR RATING
1..100
6197
PRICE GROWTH RATING
1..100
3782
P/E GROWTH RATING
1..100
61100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMRN's Valuation (22) in the Biotechnology industry is in the same range as BVNKF (50) in the null industry. This means that IMRN’s stock grew similarly to BVNKF’s over the last 12 months.

BVNKF's Profit vs Risk Rating (81) in the null industry is in the same range as IMRN (100) in the Biotechnology industry. This means that BVNKF’s stock grew similarly to IMRN’s over the last 12 months.

BVNKF's SMR Rating (61) in the null industry is somewhat better than the same rating for IMRN (97) in the Biotechnology industry. This means that BVNKF’s stock grew somewhat faster than IMRN’s over the last 12 months.

BVNKF's Price Growth Rating (37) in the null industry is somewhat better than the same rating for IMRN (82) in the Biotechnology industry. This means that BVNKF’s stock grew somewhat faster than IMRN’s over the last 12 months.

BVNKF's P/E Growth Rating (61) in the null industry is somewhat better than the same rating for IMRN (100) in the Biotechnology industry. This means that BVNKF’s stock grew somewhat faster than IMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BVNKFIMRN
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
54%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
42%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
41%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 4 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
52%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BVNKF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZUSX17.690.07
+0.40%
Lazard US Equity Focus Instl
APGYX119.190.38
+0.32%
AB Large Cap Growth Advisor
GEMRX15.14-0.01
-0.07%
abrdn Emerging Markets R
FAYZX14.91-0.02
-0.13%
Fidelity Advisor Multi-Asset Income I
VIESX17.14-0.12
-0.70%
Virtus KAR Emerging Markets Small-Cap I

BVNKF and

Correlation & Price change

A.I.dvisor tells us that BVNKF and LABFF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVNKF and LABFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVNKF
1D Price
Change %
BVNKF100%
-2.18%
LABFF - BVNKF
24%
Poorly correlated
N/A
SILO - BVNKF
22%
Poorly correlated
+0.89%
GOVX - BVNKF
22%
Poorly correlated
-2.77%
MBXBF - BVNKF
21%
Poorly correlated
N/A
IMRN - BVNKF
20%
Poorly correlated
-1.15%
More